5-aminolevulinic acid-photodynamic therapy as a potential approach for kerion
- 5 April 2022
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 38, 102855
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Remember kerion celsiBMJ Case Reports, 2013
- Inflammatory Tinea capitis: a 12‐year study and a review of the literatureMycoses, 2012
- Tinea capitis: still an unsolved problem?Mycoses, 2011
- Guidelines for the Management of Tinea Capitis in ChildrenPediatric Dermatology, 2010
- Antifungal photodynamic therapyMicrobiological Research, 2008
- Clade-related amphotericin B resistance among South African Candida albicans isolatesDiagnostic Microbiology and Infectious Disease, 2005
- Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicansAntimicrobial Agents and Chemotherapy, 2004
- Photodynamic therapy of interdigital mycoses of the feet with topical application of 5‐aminolevulinic acidPhotodermatology, Photoimmunology & Photomedicine, 2004
- Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicansAntimicrobial Agents and Chemotherapy, 2004
- Terbinafine in the Treatment of Trichophyton Tinea Capitis: A Randomized, Double-Blind, Parallel-Group, Duration-Finding StudyPediatrics, 2002